metricas
covid
Annals of Hepatology Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Rela...
Journal Information

Statistics

Follow this link to access the full text of the article

Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment
Bashar Aqel
,
Corresponding author
Aqel.bashar@mayo.edu

Correspondence and reprint request:
, Michael Leise***, Hugo E. Vargas*, Kymberly D. Watt***, Andrew P. Keaveny**, Nan Zhang****, Surakit Pungpapong**
* Division of Gastroenterology and Hepatology, Mayo Clinic in Arizona, USA
** Department of Transplant, Mayo Clinic in Florida, USA
*** Division of Gastroenterology and Hepatology, Mayo Clinic in Minnesota, USA
**** Department of Health Science Research, Section of Biostatistics, Mayo Clinic in Arizona, USA
Read
1969
Times
was read the article
499
Total PDF
1470
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 14 6 20
2025 11 43 32 75
2025 10 29 22 51
2025 9 20 13 33
2025 8 30 8 38
2025 7 24 5 29
2025 6 25 1 26
2025 5 21 4 25
2025 4 31 3 34
2025 3 16 2 18
2025 2 11 2 13
2025 1 20 3 23
2024 12 11 1 12
2024 11 18 4 22
2024 10 10 2 12
2024 9 12 1 13
2024 8 20 2 22
2024 7 20 2 22
2024 6 16 4 20
2024 5 24 1 25
2024 4 16 10 26
2024 3 33 3 36
2024 2 41 5 46
2024 1 29 3 32
2023 12 26 6 32
2023 11 52 8 60
2023 10 31 6 37
2023 9 22 3 25
2023 8 17 5 22
2023 7 26 1 27
2023 6 28 2 30
2023 5 70 10 80
2023 4 56 2 58
2023 3 25 2 27
2023 2 21 2 23
2023 1 13 2 15
2022 12 14 11 25
2022 11 15 6 21
2022 10 15 5 20
2022 9 19 9 28
2022 8 13 9 22
2022 7 16 9 25
2022 6 19 7 26
2022 5 18 12 30
2022 4 8 7 15
2022 3 18 11 29
2022 2 13 4 17
2022 1 15 4 19
2021 12 17 9 26
2021 11 10 10 20
2021 10 13 11 24
2021 9 11 8 19
2021 8 11 5 16
2021 7 7 11 18
2021 6 6 13 19
2021 5 15 13 28
2021 4 8 10 18
2021 3 20 6 26
2021 2 13 5 18
2021 1 9 12 21
2020 12 10 6 16
2020 11 9 4 13
2020 10 7 4 11
2020 9 10 9 19
2020 8 14 3 17
2020 7 6 6 12
2020 6 10 1 11
2020 5 17 7 24
2020 4 7 2 9
2020 3 6 5 11
2020 2 10 3 13
2020 1 10 4 14
2019 12 10 3 13
2019 11 3 2 5
2019 10 17 5 22
2019 9 11 8 19
2019 8 10 2 12
2019 7 10 11 21
2019 6 26 10 36
2019 5 23 9 32
Show all

Follow this link to access the full text of the article